Patients Finding a long-term fix to UK’s growing patient waiting list The pandemic severely hindered the UK’s ability to treat patients in need.
Patients How the rise of medical device use in pharma R&D is driving ... As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand.
Patients The paradox of cardiovascular disease: Out in the open, but ... When prompted with the question, ’What is the world’s deadliest disease?’, what would be your first guess?
Patients Understanding patient flow forecasting Patient flow forecasting is a fundamental tool in healthcare and pharmaceutical industries, enabling stakeholders to predict and plan for the treatment requirements of patients accurately.<
Patients The NHS risk crisis: The failure of risk in a complex health... *Disclaimer: The views and opinions expressed here are the author’s own and do not necessarily reflect those of pharmaphorum or its editorial staff.
Patients Leveraging technology for better women’s healthcare outcomes The global digital health market is expected to be valued a
News Daiichi and AZ pull Dato-DXd filing in Europe too AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
